Connect Biopharmaceuticals raises $20 mln
Connect Biopharmaceuticals Ltd said Jan. 25 that it completed a $20 million Series A financing led by Qiming Venture Partners. Also participating were Northern Light Venture Capital, Lapam Capital and Cowin Venture Capital. Connect Biopharmaceutical, of Taicang, Suzhou, is a clinical-stage company that discovers and develops immune modulators for the treatment of inflammation and cancer.
25 January 2017•5 mins read
